Vioxx appeal to go before New Jersey court

Jul 25, 2006

The New Jersey Supreme Court reportedly has agreed to hear Merck & Co.'s appeal of the class certification of a Vioxx lawsuit.

The Wall Street Journal, quoting a Merck spokesman, reported the suit, brought by a union and several other third-party payers, seeks reimbursement for up to $9.6 billion of Vioxx purchases.

The lawsuit was certified as a class action petition last July and later upheld by a state appellate court. Whitehouse Station, N.J.-based Merck then appealed to the state Supreme Court.

Vioxx was taken off the market in September 2004 after a study linked the painkiller to an increased risk of heart attack and stroke. Since then more than 14,000 lawsuits have been filed against the company, the report said.

Under New Jersey's rigorous consumer laws, awards in such cases can be tripled, the Journal said.

Copyright 2006 by United Press International

Explore further: iPhones gain in Europe, China; 'phablets' on the rise

Related Stories

Science denied: Why does doubt persist?

Oct 12, 2012

The sign in front of the tall display case at the Smithsonian Institution's Museum of Natural History lures visitors to "meet one of your oldest relatives." Inside stands a morganucodon, a mouse-like animal ...

Mass. doctor accused of faking pain pill data

Mar 11, 2009

(AP) -- A Massachusetts anesthesiologist has been accused of faking data for a dozen years in 21 published studies that suggested after-surgery benefits from painkillers including Vioxx and Celebrex.

Recommended for you

Current tech boom is no dot-com bubble, experts say

16 hours ago

Silicon Valley's tech cup runneth over. Job growth is humming, coders are being lionized on HBO, Uber and its shared-economy cohorts are on fire, disrupted innovation is unfolding on every corner. And everyone from downtown ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.